Clinical trial
Electrophysiologic Measures of Treatment Response in Alzheimer Disease
NCT00018278 · US Department of Veterans Affairs, U.S. Fed · Completed
Key facts
| NCT number | NCT00018278 |
|---|---|
| Title | Electrophysiologic Measures of Treatment Response in Alzheimer Disease |
| Official title | Verbal Memory ERPs as Indices of Treatment Response in Alzheimer Disease |
| Lead sponsor | US Department of Veterans Affairs, U.S. Fed |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Alzheimer Disease |
| Intervention type | Drug |
| Interventions | Aricept, Exelon, Nicoderm Patch |
| Start date | Oct 1, 1998 |
| Completion | Sep 1, 2001 |
| First posted | Jul 5, 2001 |
| Last update posted | Jan 21, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: